LabCorp

Summary

LabCorp is the famous Corporate Investor, which was founded in 1976. The main office of represented Corporate Investor is situated in the Burlington. The venture was found in North America in United States.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Cloud Computing, Medical Device. Among the most popular portfolio startups of the fund, we may highlight Flatiron Health, ORIG3N, Navigating Cancer.

The fund is constantly included in 2-6 deals per year. The increased amount of exits for fund were in 2019. The high activity for fund was in 2019. Opposing the other organizations, this LabCorp works on 22 percentage points less the average amount of lead investments. Speaking about the real fund results, this Corporate Investor is 0 percentage points less often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. When the investment is from LabCorp the average startup value is 10-50 millions dollars.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the LabCorp, startups are often financed by General Catalyst, Hatteras Venture Partners, 180 Degree Capital. The meaningful sponsors for the fund in investment in the same round are Hatteras Venture Partners, GV, DEFTA Partners. In the next rounds fund is usually obtained by The Kraft Group, Spectrum Health Ventures, Hatteras Venture Partners.